Decreased Skeletal Muscle Mass After Neoadjuvant Therapy Correlates with Poor Prognosis in Patients with Esophageal Cancer.

@article{Liu2016DecreasedSM,
  title={Decreased Skeletal Muscle Mass After Neoadjuvant Therapy Correlates with Poor Prognosis in Patients with Esophageal Cancer.},
  author={Jiajia Liu and Satoru Motoyama and Yusuke Sato and Akiyuki Wakita and Yuta Kawakita and Hajime Saito and Yoshihiro Minamiya},
  journal={Anticancer research},
  year={2016},
  volume={36 12},
  pages={6677-6685}
}
BACKGROUND Loss of skeletal muscle is predictive of a poor prognosis in patients with various malignant lesions. Our aim was to determine whether changes in skeletal muscle after neo-adjuvant therapy (NAT) predict prognosis in patients with esophageal squamous cell carcinoma (ESCC) undergoing esophagectomy. PATIENTS AND METHODS The cross-sectional areas of the psoas muscles were measured on computed tomographic images collected at the initial visit, preoperatively and postoperatively in 84… CONTINUE READING